Multiplexed biomarker assay for classification of patients with systemic sclerosis
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201500058C
- Awardee
-
Celdara Medical, LLC UEI MMVKQXZUBMQ7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,499,989
Award facts
- Opportunity
-
- N44TR15001 Solicitation number
- Contract value 100% obligated
- $1,499,989.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, NH 03766, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,499,989 |
About this award
This is a $1,499,989.00 Firm Fixed Price contract awarded by the National Center for Advancing Translational Sciences (NCATS) to Celdara Medical, LLC, a small disadvantaged business. The contract is for the development of a Multiplexed Biomarker Assay for the Classification of Patients with Systemic Sclerosis, under the SBIR Program Phase II. This research and development contract aims to create a new diagnostic tool for systemic sclerosis, an autoimmune disease affecting the skin and internal organs. The contract has a completion date of September 14, 2017 and was set aside for small businesses.
Quick answers
Who was awarded contract HHSN271201500058C?
HHSN271201500058C was awarded to Celdara Medical, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 14, 2015.
How much is contract HHSN271201500058C worth?
The government has obligated $1,499,989 on HHSN271201500058C.
Which agency awarded contract HHSN271201500058C?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201500058C, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract HHSN271201500058C competed?
The extent of competition for HHSN271201500058C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award